comparemela.com

Latest Breaking News On - Empirical asset management - Page 14 : comparemela.com

1,802 Shares in SBA Communications Co (NASDAQ:SBAC) Bought by Empirical Asset Management LLC

Empirical Asset Management LLC purchased a new position in shares of SBA Communications Co. (NASDAQ:SBAC – Get Rating) in the first quarter, HoldingsChannel.com reports. The firm purchased 1,802 shares of the technology company’s stock, valued at approximately $471,000. A number of other large investors have also recently bought and sold shares of SBAC. Raymond James […]

Empirical Asset Management LLC Has $425,000 Stake in Sysco Co (NYSE:SYY)

Empirical Asset Management LLC decreased its stake in Sysco Co. (NYSE:SYY – Get Rating) by 8.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,509 shares of the company’s stock after selling 523 shares during the quarter. Empirical Asset […]

Empirical Asset Management LLC Acquires Shares of 3,371 CDW Co (NASDAQ:CDW)

Empirical Asset Management LLC acquired a new stake in shares of CDW Co. (NASDAQ:CDW – Get Rating) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 3,371 shares of the information technology services provider’s stock, valued at approximately $657,000. Several other large investors have also bought and sold […]

Vanguard S&P 500 ETF (NYSEARCA:VOO) Shares Sold by Empirical Asset Management LLC

Empirical Asset Management LLC cut its position in shares of Vanguard S&P 500 ETF (NYSEARCA:VOO – Get Rating) by 5.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 733 shares of the company’s stock after selling 46 shares during the quarter. Empirical Asset Management […]

Empirical Asset Management LLC Acquires 7,412 Shares of Gilead Sciences, Inc (NASDAQ:GILD)

Empirical Asset Management LLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 54.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 21,007 shares of the biopharmaceutical company’s stock after buying an additional 7,412 shares during the period. Gilead Sciences accounts for […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.